Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

Allergy Therapeutics plc

AGYTF•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$0.11
$0.00(0.00%)
U.S. Market opens in NaNh NaNm

Allergy Therapeutics plc (AGYTF) Stock Overview

Explore Allergy Therapeutics plc’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap504.6M
P/E Ratio-9.70
EPS (TTM)$-0.01
ROE1.75%
Fundamental Analysis

AI Price Forecasts

1 Month$0.12
3 Months$0.16
1 Year Target$0.00

AGYTF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Allergy Therapeutics plc (AGYTF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 0.00, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -9.70 and a market capitalization of 504.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
29.41%
Year-to-Date (YTD) Change
N/A
1-Year Change
111.54%
3-Year Change
-30.82%
5-Year Change
-54.17%
All-Time (Max) Change
-45.00%

Contact Information

https://www.allergytherapeutics.com
44 1903 844 700
Dominion Way, Worthing, NaN, BN14 8SA

Company Facts

6,120 Employees
IPO DateFeb 3, 2010
CountryGB
Actively Trading

Frequently Asked Questions